Previous close | 1.7500 |
Open | 2.0500 |
Bid | 7.1000 |
Ask | 8.2000 |
Strike | 12.50 |
Expiry date | 2024-05-17 |
Day's range | 1.7500 - 2.0500 |
Contract range | N/A |
Volume | |
Open interest | N/A |
On May 14, 2024, Director Jane Kiernan purchased 19,356 shares of Treace Medical Concepts Inc (NASDAQ:TMCI), as reported in the SEC Filing.
On May 10, 2024, Deepti Jain, Director at Treace Medical Concepts Inc (NASDAQ:TMCI), purchased 25,000 shares of the company, as reported in a recent SEC Filing.
On May 13, 2024, Richard Mott, a Director at Treace Medical Concepts Inc (NASDAQ:TMCI), purchased 120,000 shares of the company, as reported in a recent SEC Filing.